Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson (MCK) Rises As Market Takes a Dip: Key Facts
In the latest trading session, McKesson (MCK) closed at $513.67, marking a +0.86% move from the previous day.
Here's Why McKesson (MCK) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) Stock Sinks As Market Gains: Here's Why
The latest trading day saw McKesson (MCK) settling at $479.06, representing a -0.02% change from its previous close.
McKesson - Meet The New Dividend Stock On My Watchlist
McKesson's recent sell-off offers a compelling opportunity, driven by its strong position in healthcare distribution and growing focus on AI and technology for sustainable growth. The company boast...
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cash
McKesson Corp. MCK, -1.56% said Monday it has agreed to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures, LLC , or Core Ventures, a physician-owned community onc...
McKesson (MCK) Stock Gains 18% YTD: What's Driving the Rally?
McKesson's (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.
McKesson Revenue Hurt by Supply and Demand Issues for Weight-Loss Drugs
McKesson (MCK) shares tumbled Thursday, a day after the healthcare services provider warned that limited supply of GLP-1 weight-loss drugs is hurting sales.
McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y
McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
3 Healthcare Stocks Positioned for Possible Market Outperformance
So far in 2024, healthcare stocks have run into periodic earnings challenges compared to historical first quarters. For example, quarterly earnings for healthcare stocks across the board were down ...
3 Reasons Why You Should Hold McKesson (MCK) Stock for Now
McKesson's (MCK) robust Biologics business raises optimism about the stock.
McKesson (MCK) Declines More Than Market: Some Information for Investors
In the latest trading session, McKesson (MCK) closed at $575.23, marking a -1.98% move from the previous day.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.
Related Companies